NCT02877485View on ClinicalTrials.gov

The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 15, 2019

Study Completion Date

August 15, 2019

Conditions
Nasal Obstruction
Interventions
DRUG

Triamcinolone Acetonide

2 sprays sprayed to both nostrils daily for 42 days.

DRUG

Ayr saline nasal mist

110mcg (2 sprays) sprayed to both nostrils daily for 42 days.

Trial Locations (1)

94305

Stanford Hospital and Clinics, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT02877485 - The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation | Biotech Hunter | Biotech Hunter